ValitaCellWednesday, 21 September 2022
ByrneWallace LLP is delighted to have acted for ValitaCell on its acquisition by Beckman Coulter Life Sciences, a Danaher Corporation Subsidiary, global leader in laboratory automation and innovation.
Headquartered in Dublin, Ireland, ValitaCell creates pioneering analytical technologies and products for the biopharmaceutical industry with the goal of reducing new therapeutics’ cost and time to market.
This was a high-value, cross-jurisdictional deal which required input from a number of our specialist areas and highlights our team’s expertise in handling complex, cross-border transactions.
The ByrneWallace LLP team who advised on this includes Catherine Dowling (Corporate & Life Sciences, Partner), Colin Sainsbury (Partner and Head of Life Sciences), Aisling Brennan (Senior Associate, Corporate), Emmet Connolly (Associate, Corporate), John O’Connor (Solicitor, Corporate), Zelda Deasy (Partner, Data Protection), Colin Bolger (ByrneWallace Tax Advisors), Liam Connellan (Partner and head of Pension Law) and Pádraig Murray (Associate, Property).
For further details, see the press release and press coverage below.